Taiwachelin
| Internal ID | 4e8ca37a-c0a4-4324-98a1-9dc278d199d1 |
| Taxonomy | Organic acids and derivatives > Carboxylic acids and derivatives > Amino acids, peptides, and analogues > Peptides > Oligopeptides |
| IUPAC Name | (2S,3S)-4-[[(2R,3R)-1-[[(2S)-3-carboxy-1-[[(2R)-5-[hydroxy-[(3S)-3-hydroxybutanoyl]amino]-1-[[(2S)-3-hydroxy-1-[[(3S)-1-hydroxy-2-oxopiperidin-3-yl]amino]-1-oxopropan-2-yl]amino]-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-3-(dodecanoylamino)-2-hydroxy-4-oxobutanoic acid |
| SMILES (Canonical) | |
| SMILES (Isomeric) | |
| InChI | InChI=1S/C41H70N8O18/c1-4-5-6-7-8-9-10-11-12-17-29(53)46-33(34(57)41(64)65)39(62)47-32(24(3)52)38(61)44-27(21-31(55)56)36(59)42-25(15-13-18-48(66)30(54)20-23(2)51)35(58)45-28(22-50)37(60)43-26-16-14-19-49(67)40(26)63/h23-28,32-34,50-52,57,66-67H,4-22H2,1-3H3,(H,42,59)(H,43,60)(H,44,61)(H,45,58)(H,46,53)(H,47,62)(H,55,56)(H,64,65)/t23-,24+,25+,26-,27-,28-,32+,33-,34-/m0/s1 |
| InChI Key | DSEHLJGXEXFDGA-UVWMAGHCSA-N |
| Popularity | 2 references in papers |
| Molecular Formula | C41H70N8O18 |
| Molecular Weight | 963.00 g/mol |
| Exact Mass | 962.48080741 g/mol |
| Topological Polar Surface Area (TPSA) | 411.00 Ų |
| XlogP | -1.40 |
| Atomic LogP (AlogP) | -3.11 |
| H-Bond Acceptor | 16 |
| H-Bond Donor | 14 |
| Rotatable Bonds | 33 |
| There are no found synonyms. |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | - | 0.6588 | 65.88% |
| Caco-2 | - | 0.8583 | 85.83% |
| Blood Brain Barrier | - | 0.8000 | 80.00% |
| Human oral bioavailability | - | 0.7143 | 71.43% |
| Subcellular localzation | Mitochondria | 0.6270 | 62.70% |
| OATP2B1 inhibitior | - | 1.0000 | 100.00% |
| OATP1B1 inhibitior | + | 0.8604 | 86.04% |
| OATP1B3 inhibitior | + | 0.9262 | 92.62% |
| MATE1 inhibitior | - | 1.0000 | 100.00% |
| OCT2 inhibitior | - | 0.9250 | 92.50% |
| BSEP inhibitior | + | 0.7854 | 78.54% |
| P-glycoprotein inhibitior | + | 0.7375 | 73.75% |
| P-glycoprotein substrate | + | 0.7843 | 78.43% |
| CYP3A4 substrate | + | 0.7148 | 71.48% |
| CYP2C9 substrate | - | 0.7984 | 79.84% |
| CYP2D6 substrate | - | 0.8544 | 85.44% |
| CYP3A4 inhibition | - | 0.7740 | 77.40% |
| CYP2C9 inhibition | - | 0.8345 | 83.45% |
| CYP2C19 inhibition | - | 0.8285 | 82.85% |
| CYP2D6 inhibition | - | 0.8666 | 86.66% |
| CYP1A2 inhibition | - | 0.8867 | 88.67% |
| CYP2C8 inhibition | + | 0.4917 | 49.17% |
| CYP inhibitory promiscuity | - | 0.9795 | 97.95% |
| UGT catelyzed | - | 0.5000 | 50.00% |
| Carcinogenicity (binary) | - | 0.7600 | 76.00% |
| Carcinogenicity (trinary) | Non-required | 0.5318 | 53.18% |
| Eye corrosion | - | 0.9821 | 98.21% |
| Eye irritation | - | 0.8971 | 89.71% |
| Skin irritation | - | 0.7639 | 76.39% |
| Skin corrosion | - | 0.9304 | 93.04% |
| Ames mutagenesis | - | 0.6600 | 66.00% |
| Human Ether-a-go-go-Related Gene inhibition | - | 0.4449 | 44.49% |
| Micronuclear | + | 0.7800 | 78.00% |
| Hepatotoxicity | - | 0.5916 | 59.16% |
| skin sensitisation | - | 0.8485 | 84.85% |
| Respiratory toxicity | + | 0.6556 | 65.56% |
| Reproductive toxicity | + | 0.8222 | 82.22% |
| Mitochondrial toxicity | + | 0.8875 | 88.75% |
| Nephrotoxicity | + | 0.8366 | 83.66% |
| Acute Oral Toxicity (c) | III | 0.6192 | 61.92% |
| Estrogen receptor binding | + | 0.7861 | 78.61% |
| Androgen receptor binding | + | 0.6246 | 62.46% |
| Thyroid receptor binding | + | 0.5196 | 51.96% |
| Glucocorticoid receptor binding | + | 0.5422 | 54.22% |
| Aromatase binding | + | 0.6340 | 63.40% |
| PPAR gamma | + | 0.6950 | 69.50% |
| Honey bee toxicity | - | 0.8288 | 82.88% |
| Biodegradation | - | 0.7500 | 75.00% |
| Crustacea aquatic toxicity | - | 0.5124 | 51.24% |
| Fish aquatic toxicity | - | 0.4064 | 40.64% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL2581 | P07339 | Cathepsin D | 99.91% | 98.95% |
| CHEMBL4040 | P28482 | MAP kinase ERK2 | 99.80% | 83.82% |
| CHEMBL3468 | P55210 | Caspase-7 | 98.59% | 95.68% |
| CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 98.21% | 99.17% |
| CHEMBL1795139 | Q8IU80 | Transmembrane protease serine 6 | 97.50% | 98.33% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 97.48% | 96.09% |
| CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 96.57% | 93.56% |
| CHEMBL2107 | P61073 | C-X-C chemokine receptor type 4 | 96.54% | 93.10% |
| CHEMBL221 | P23219 | Cyclooxygenase-1 | 95.94% | 90.17% |
| CHEMBL3776 | Q14790 | Caspase-8 | 95.85% | 97.06% |
| CHEMBL4588 | P22894 | Matrix metalloproteinase 8 | 95.85% | 94.66% |
| CHEMBL3392948 | Q9NP59 | Solute carrier family 40 member 1 | 95.49% | 95.00% |
| CHEMBL5103 | Q969S8 | Histone deacetylase 10 | 95.21% | 90.08% |
| CHEMBL321 | P14780 | Matrix metalloproteinase 9 | 95.07% | 92.12% |
| CHEMBL3629 | P68400 | Casein kinase II alpha | 94.71% | 98.89% |
| CHEMBL4801 | P29466 | Caspase-1 | 94.39% | 96.85% |
| CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 93.93% | 93.00% |
| CHEMBL5043 | Q6P179 | Endoplasmic reticulum aminopeptidase 2 | 93.66% | 91.81% |
| CHEMBL2334 | P42574 | Caspase-3 | 93.52% | 98.25% |
| CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 92.72% | 96.90% |
| CHEMBL3130 | O00329 | PI3-kinase p110-delta subunit | 92.46% | 96.47% |
| CHEMBL4685 | P14902 | Indoleamine 2,3-dioxygenase | 92.23% | 96.38% |
| CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 92.03% | 90.71% |
| CHEMBL2514 | O95665 | Neurotensin receptor 2 | 91.90% | 100.00% |
| CHEMBL4187 | Q99250 | Sodium channel protein type II alpha subunit | 89.79% | 95.50% |
| CHEMBL230 | P35354 | Cyclooxygenase-2 | 89.33% | 89.63% |
| CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 88.93% | 97.14% |
| CHEMBL4618 | P09960 | Leukotriene A4 hydrolase | 88.73% | 97.86% |
| CHEMBL1907591 | P30926 | Neuronal acetylcholine receptor; alpha4/beta4 | 88.39% | 100.00% |
| CHEMBL1944495 | P28065 | Proteasome subunit beta type-9 | 88.19% | 97.50% |
| CHEMBL5255 | O00206 | Toll-like receptor 4 | 88.07% | 92.50% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 87.61% | 97.09% |
| CHEMBL3524 | P56524 | Histone deacetylase 4 | 87.36% | 92.97% |
| CHEMBL340 | P08684 | Cytochrome P450 3A4 | 87.13% | 91.19% |
| CHEMBL2001 | Q9H244 | Purinergic receptor P2Y12 | 86.81% | 96.00% |
| CHEMBL3038477 | P67870 | Casein kinase II alpha/beta | 86.56% | 99.23% |
| CHEMBL4227 | P25090 | Lipoxin A4 receptor | 85.90% | 100.00% |
| CHEMBL259 | P32245 | Melanocortin receptor 4 | 85.47% | 95.38% |
| CHEMBL4296 | Q15858 | Sodium channel protein type IX alpha subunit | 85.15% | 96.11% |
| CHEMBL2534 | O15530 | 3-phosphoinositide dependent protein kinase-1 | 84.97% | 95.36% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 84.82% | 94.45% |
| CHEMBL1293316 | Q9HBX9 | Relaxin receptor 1 | 84.28% | 82.50% |
| CHEMBL3430907 | Q96GD4 | Aurora kinase B/Inner centromere protein | 84.18% | 97.50% |
| CHEMBL2693 | Q9UIQ6 | Cystinyl aminopeptidase | 83.79% | 97.64% |
| CHEMBL2274 | Q9H228 | Sphingosine 1-phosphate receptor Edg-8 | 83.55% | 100.00% |
| CHEMBL236 | P41143 | Delta opioid receptor | 83.34% | 99.35% |
| CHEMBL1907603 | Q05586 | Glutamate NMDA receptor; GRIN1/GRIN2B | 82.93% | 95.89% |
| CHEMBL335 | P18031 | Protein-tyrosine phosphatase 1B | 82.74% | 95.17% |
| CHEMBL2111367 | P27986 | PI3-kinase p110-alpha/p85-alpha | 82.47% | 94.33% |
| CHEMBL2474 | P53582 | Methionine aminopeptidase 1 | 82.31% | 97.09% |
| CHEMBL2781 | P19634 | Sodium/hydrogen exchanger 1 | 82.18% | 90.24% |
| CHEMBL4330 | Q9NS75 | Cysteinyl leukotriene receptor 2 | 82.07% | 98.00% |
| CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 82.07% | 95.56% |
| CHEMBL237 | P41145 | Kappa opioid receptor | 81.96% | 98.10% |
| CHEMBL1075094 | Q16236 | Nuclear factor erythroid 2-related factor 2 | 81.79% | 96.00% |
| CHEMBL2069156 | Q14145 | Kelch-like ECH-associated protein 1 | 81.77% | 82.38% |
| CHEMBL3892 | Q99500 | Sphingosine 1-phosphate receptor Edg-3 | 81.76% | 97.29% |
| CHEMBL3024 | P53350 | Serine/threonine-protein kinase PLK1 | 81.73% | 97.43% |
| CHEMBL2072 | P35499 | Sodium channel protein type IV alpha subunit | 81.47% | 92.32% |
| CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 81.33% | 95.89% |
| CHEMBL2094135 | Q96BI3 | Gamma-secretase | 80.91% | 98.05% |
| CHEMBL220 | P22303 | Acetylcholinesterase | 80.88% | 94.45% |
| CHEMBL5028 | O14672 | ADAM10 | 80.75% | 97.50% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 71492379 |
| LOTUS | LTS0152814 |
| wikiData | Q104987802 |